Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis

被引：3
|
作者：
Singal, Amit G. [1 ,4 ]
Nagar, Saurabh P. [2 ]
Hitchens, Abby [2 ]
Davis, Keith L. [2 ]
Iyer, Shrividya [2 ,3 ]
机构：
[1] UT Southwestern Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Digest Dis Ctr, Div Digest & Singal, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 03期
关键词：
SORAFENIB;
D O I：
10.1016/j.cgh.2021.11.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    FUTURE ONCOLOGY, 2021, 17 (21) : 2759 - 2768
  • [2] Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto., Naoya
    JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
  • [3] Real-World Burden of Nonalcoholic Steatohepatitis
    Geier, Andreas
    Rinella, Mary E.
    Balp, Maria-Magdalena
    McKenna, Sarah Jane
    Brass, Clifford A.
    Przybysz, Raymond
    Cai, Jennifer
    Knight, Amanda
    Gavaghan, Meghan
    Howe, Tanya
    Rosen, Daniel
    Ratziu, Vlad
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (05) : 1020 - +
  • [4] Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights
    de Castria, Tiago Biachi
    Kim, Richard
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2024, 15 : 79 - 87
  • [5] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Kimura, Megumi
    Shimazaki, Tomoe
    Maehara, Osamu
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Ohara, Masatsugu
    Umemura, Machiko
    Kawagishi, Naoki
    Natsuizaka, Mitsuteru
    Nakai, Masato
    Morikawa, Kenichi
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Meguro, Takashi
    Saga, Akiyoshi
    Miyagishima, Takuto
    Yokoo, Hideki
    Kamiyama, Toshiya
    Taketomi, Akinobu
    Sakamoto, Naoya
    JGH OPEN, 2020, 4 (01): : 54 - 60
  • [6] Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma
    Wang, Hung-Wei
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Kao, Jung-Ta
    Hsu, Wei-Fan
    Chen, Hung-Yao
    Chang, Che-Wei
    Huang, Guan-Tarn
    Peng, Cheng-Yuan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (05)
  • [7] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E621 - E621
  • [8] Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    Etsuko Hashimoto
    Satoru Yatsuji
    Maki Tobari
    Makiko Taniai
    Nobuyuki Torii
    Katsutoshi Tokushige
    Keiko Shiratori
    Journal of Gastroenterology, 2009, 44 : 89 - 95
  • [9] Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    Hashimoto, Etsuko
    Yatsuji, Satoru
    Tobari, Maki
    Taniai, Makiko
    Torii, Nobuyuki
    Tokushige, Katsutoshi
    Shiratori, Keiko
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 89 - 95
  • [10] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Jinbin Chen
    Peiyao Xiong
    Man Nie
    Yangxun Pan
    Juncheng Wang
    Dandan Hu
    Zhongguo Zhou
    Yaojun Zhang
    Minshan Chen
    Li Xu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2491 - 2500
12345